
Alpha Profiles · Company Profile
Shattuck Labs, Inc.
Shattuck Labs, Inc. operates as a biotechnology firm based in the United States, currently at the clinical development stage.
https://registry.alpha.ac/companies/shattuck-labs-inc
- Entity
- Public listing published
- Primary listing
- NASDAQ: STTK
- Verification
- Partially verified
- Last reviewed
- 2026-10-12T04:46:16.596626+00:00
Overview
Shattuck Labs, Inc. operates as a biotechnology firm based in the United States, currently at the clinical development stage. Its core mission is to create innovative therapeutics designed to combat both cancer and autoimmune diseases. The company's leading experimental compound, SL-172154, is presently undergoing Phase 1 clinical assessment for the treatment of ovarian, fallopian tube, and peritoneal cancers.
Source record
Alpha canonical company public projection
Supports Company identity, Published leadership, Entity status boundary
Reviewed 2026-10-12T04:46:16.596626+00:00
